콘텐츠로 건너뛰기
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Menu
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Get In Touch

Press Release

HOME > NEWS > Press Release​

[New drug development using AI] Molecular design using generative models

READ MORE

PharmCADD signed a co-development agreement of novel anticancer drug discovery with KYNOGEN

READ MORE

PharmCADD will create an innovative AI drug and will be listed on KOSDAQ in March 2022.

READ MORE

PharmCADD accomplished funding and strategic alliances with Huons and other biopharmaceutical companies.

READ MORE

PharmCADD’s mRNA vaccine candidate showed reliable immunogenicity in animal model

READ MORE

PharmCADD & ADEL collaborate to develop an Alzheimer’s disease novel drug

READ MORE

PharmCADD is developing a COVID-19 vaccine with AI-based drug discovery platform technology

READ MORE

Posing for a better future

READ MORE

PharmCADD attended the invitation of the Embassy of Algeria – Presentation of COVID19 mRNA vaccine

READ MORE
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681
Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.